Workflow to facilitate the detection of new psychoactive substances and drugs of abuse in influent urban wastewater
Date
2024
Authors
Bade, R.
van Herwerden, D.
Rousis, N.
Adhikari, S.
Jaunay, E.
Mueller, J.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Journal of Hazardous Materials, 2024; 469(133955):1-11
Statement of Responsibility
Conference Name
Abstract
The complexity around the dynamic markets for new psychoactive substances (NPS) forces researchers to develop and apply innovative analytical strategies to detect and identify them in influent urban wastewater. In this work a comprehensive suspect screening workflow following liquid chromatography – high resolution mass spectrometry analysis was established utilising the open-source InSpectra data processing platform and the HighResNPS library. In total, 278 urban influent wastewater samples from 47 sites in 16 countries were collected to investigate the presence of NPS and other drugs of abuse. A total of 50 compounds were detected in samples from at least one site. Most compounds found were prescription drugs such as gabapentin (detection frequency 79%), codeine (40%) and pregabalin (15%). However, cocaine was the most found illicit drug (83%), in all countries where samples were collected apart from the Republic of Korea and China. Eight NPS were also identified with this protocol: 3-methylmethcathinone 11%), eutylone (6%), etizolam (2%), 3-chloromethcathinone (4%), mitragynine (6%), phenibut (2%), 25I-NBOH (2%) and trimethoxyamphetamine (2%). The latter three have not previously been reported in municipal wastewater samples. The workflow employed allowed the prioritisation of features to be further investigated, reducing processing time and gaining in confidence in their identification.
School/Discipline
Dissertation Note
Provenance
Description
Data source: Supplementary material, https://doi.org/10.1016/j.jhazmat.2024.133955
Access Status
Rights
Copyright 2024 The Author(s). This is an open access article under the CC BY license. (https://creativecommons.org/licenses/by/4.0/)